65,437 trials
Colorectal Cancer
Primary: Percentage of Participants With Adverse Events — 76.4; 68.0 percentage of participants
Depression · Cystic Fibrosis
Primary: Length of Hospitalization — 11 days
Colorectal Cancer
Primary: Objective Response Rate (ORR) in the Intent-to-treat (ITT) Analysis Set — 54.5 percentage of participants
Lung Cancer
Primary: Overall Survival — 29.8 months
Acute Respiratory Distress Syndrome (ARDS)
Primary: Change in Oxygen Saturation to Fraction of Inspired Oxygen Concentration (SpO2/FiO2) Ratio — 320; 334; 376; 336 SpO2/FiO2 Ratio — p=0.02
Perimenopausal Depression · Depression
Primary: Center for Epidemiologic Studies-Depression Scale (CES-D) — 27.4; 29.1; 28.8; 24.6 Units on a scale
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26 — -0.01; -0.91 percentage of glycosylated hemoglobin
Stress Disorders, Post-Traumatic
Primary: PTSD Symptoms — 71.1; 71.0 CAPS scores — p=0.97
Eosinophilic Esophagitis
Primary: Mean Percent Change From Baseline to End of Treatment in Peak Esophageal Eosinophil (EE) Levels — -37.60; -58.27; -56.46; 11.50 percentage change in eosinophils/hpf…
Cerebral Arterial Aneurysm
Primary: Evidences of Clinically Definite Oxidative Stress Confirmed by ELISA Kit — 72.87; 74.02; 67.10; 65.91 U/ml
Pterygium
Primary: Number of Participants Who Had Recurrence of Pterygia up to 1 Year — 0; 3 participants
Refractive Error
Primary: Average Coefficient of Friction of Worn Lenses at 16 Hours — 0.0602; 0.0576; 0.0578 unitless
Viral Infection
Primary: Subjects With Treatment-emergent Adverse Event (TEAEs) by Treatment Group — 5; 6; 5; 5 Subjects with at least 1 TEAE
Hemophilia B
Primary: Adverse Events (AEs) Possibly or Probably Related to BAX326 — 0; 0; 0 AEs considered related to BAX326
Advanced Solid Tumors
Primary: Objective Response Rate and Duration — 0; 0; 0; 0 participants with objective response